Silver Book Fact

The annual total incremental per patient health care expenditures for heart valve disease patients ranged from $1,755 in 1996 to $12,789 in 2011.

Moore M, Chen J, Mallow P, Rizzo J. The Direct Health-Care Burden of Valvular Heart Disease: Evidence from US national survey data. Clinicoecon Outcomes Res. 2016; 8

Reference

Title
The Direct Health-Care Burden of Valvular Heart Disease: Evidence from US national survey data
Publication
Clinicoecon Outcomes Res
Publication Date
2016
Authors
Moore M, Chen J, Mallow P, Rizzo J

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Total cost of heart valve disease in the U.S.
     
  • Medicare patients with sSAS have an average lifespan of 1.8 years without repair or replacement
     
  • Distribution of inpatient and selected outpatient costs for treating atrial fibrillation
    Distribution of inpatient and selected outpatient costs for treating atrial fibrillation  
  • AFib, an economic burden
    AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study…  
  • Hospital discharges for heart failure rose from 400,000 in 1979 to 1,084,000 in 2005–an increase of 171%.